--- title: Buy Baraclude (Entecavir) 0.5mg Pills Online description: Baraclude (Entecavir) 0.5mg pills treat chronic hepatitis B virus infection. Order from our secure online pharmacy for verified quality and discreet delivery. type: product language: en url: https://liabilis.com/order-baraclude-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 134.99 price_max: 288.99 currency: USD offers: - name: 0.5mg x 30 pills price: 134.99 - name: 0.5mg x 60 pills price: 215.99 - name: 0.5mg x 90 pills price: 288.99 --- # Buy Baraclude (Entecavir) 0.5mg Pills Online Baraclude, containing entecavir, is an antiviral developed by Bristol-Myers Squibb. It suppresses hepatitis B virus replication in chronic infection. Intended for adults with evidence of active viral replication. Our online pharmacy offers a reliable way to access Baraclude in 0.5mg pills. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **0.5mg** | 30 pills | **$134.99** | $4.50 | In Stock | | **0.5mg** | 60 pills | **$215.99** | $3.60 | In Stock | | **0.5mg** | 90 pills | **$288.99** | $3.21 | In Stock | [Buy Now](https://liabilis.com/order-baraclude-online-en.html) ## Introduction Baraclude is a prescription medication used to treat chronic hepatitis B virus (HBV) infection in adults. Its active ingredient is **entecavir**, a nucleoside analogue that inhibits viral replication. Baraclude is supplied as a **pill** in a **0.5 mg** strength and belongs to the antiviral therapeutic class. In addition to its primary indication for hepatitis B, entecavir-containing products may be considered in certain off-label scenarios under specialist supervision. ## Quick Reference Facts **Active Ingredient** : Entecavir **Form** : Pill 0.5 mg **Primary and Off-Label Uses** : • Chronic hepatitis B infection (approved) : • Prevention of HBV reactivation in immunosuppressed patients (off-label) : • Use in liver transplant recipients with HBV (off-label) ## What is Baraclude? Baraclude is a branded antiviral medication that contains the active compound entecavir. It is classified as a nucleoside analogue reverse-transcriptase inhibitor and is approved for the treatment of chronic hepatitis B in adults. The product was developed by Bristol-Myers Squibb and received regulatory approval in the United States and Europe in the mid-2000s. Although Baraclude itself is a brand product, generic versions of entecavir are available worldwide, offering a lower-cost alternative that is bioequivalent to the brand formulation. ## How Baraclude Works Entecavir interferes with the hepatitis B virus DNA polymerase by mimicking the natural nucleoside guanosine. Once inside hepatocytes, entecavir is phosphorylated to its active triphosphate form, which competes with natural substrates and terminates viral DNA chain elongation. This blocks the reverse transcription step that converts pre-genomic RNA into DNA, thereby suppressing viral replication. The drug exhibits high oral bioavailability, reaches peak plasma concentrations within 0.5-1.5 hours, and is primarily eliminated unchanged by the kidneys. Its long intracellular half-life allows for once-daily dosing, providing sustained viral suppression with a favorable resistance profile when used in treatment-naïve patients. ## Conditions Treated with Baraclude - **Chronic hepatitis B infection** - Entecavir reduces serum HBV DNA levels, improves liver enzyme abnormalities, and lowers the risk of cirrhosis and hepatocellular carcinoma. The drug’s potency makes it a first-line option for patients without prior nucleos(t)ide therapy. - **HBV reactivation prophylaxis (off-label)** - In patients receiving immunosuppressive chemotherapy or biologics, entecavir may be prescribed to prevent viral flare-ups. By maintaining low viral loads, it reduces the likelihood of severe hepatitis during immune suppression. - **Post-liver transplant HBV management (off-label)** - When combined with hepatitis B immune globulin, entecavir helps maintain graft function and prevents reinfection of the transplanted liver. ## Is Baraclude the Right Medication for You? Baraclude is appropriate for adults with confirmed chronic hepatitis B who have not previously received nucleos(t)ide analogues or who are switching from a less potent agent. It is especially suitable for patients with high viral loads, elevated ALT levels, or evidence of liver fibrosis. Contraindications include known hypersensitivity to entecavir or any excipients in the tablet. Caution is advised in patients with moderate to severe renal impairment; dose adjustment may be necessary. Those with decompensated cirrhosis should be monitored closely, as abrupt discontinuation can precipitate hepatic flare. ## Buying Baraclude from [our online pharmacy](https://liabilis.com/order-baraclude-online-en.html) ### Why Choose Our Service? Our platform connects patients with trustworthy sources of Baraclude, helping to overcome geographic or cost barriers that can delay essential therapy. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. ### Pricing & Access By sourcing the medication through verified overseas suppliers, we can offer Baraclude at a price close to the manufacturer’s list, which is often lower than retail rates in many countries. ### Discreet Delivery Orders are packed in unmarked, tamper-evident envelopes and shipped via express courier (typically within 7 days) or standard airmail (approximately 3 weeks), preserving your privacy throughout the process. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** - The usual adult dose for treatment-naïve chronic hepatitis B is 0.5 mg taken orally once daily with or without food. - **Missed dose** - If a dose is forgotten, take it as soon as you remember the same day. Skip the missed dose if it is near the time of the next scheduled dose; do not double-dose. - **Suspected overdose** - Contact emergency services or a poison-control centre immediately. Symptoms may include nausea, vomiting, or dizziness, but severe toxicity is rare. - **Precautions** - Avoid excessive alcohol, as it can exacerbate liver injury. Do not operate heavy machinery until you know how the medication affects you, especially during the initial treatment period. ## Safety Information ### ⚠️ Who Should Not Take Baraclude - Patients with documented hypersensitivity to entecavir or any tablet component. - Individuals with severe renal impairment (creatinine clearance < 30 mL/min) without appropriate dose adjustment. ### Common Side Effects - Mild headache, fatigue, and upper-respiratory tract symptoms occur in up to 10 % of patients and usually resolve without intervention. - Transient increases in serum creatine kinase may be observed; staying hydrated and avoiding intense exercise can mitigate discomfort. ### Serious Side Effects (Seek Immediate Medical Help) - Signs of lactic acidosis (muscle pain, rapid breathing, abdominal discomfort). - Acute hepatic decompensation (jaundice, abdominal swelling, confusion). - Severe allergic reactions (rash, swelling of face or throat, difficulty breathing). ### Drug & Food Interactions - **Concurrent tenofovir** - May increase the risk of renal toxicity; monitor kidney function regularly. - **Antacids containing aluminum or magnesium** - Can reduce entecavir absorption; separate administration by at least 2 hours. - **Didanosine** - Concurrent use is not recommended due to heightened risk of pancreatitis. ## Off-Label and Investigational Uses of Baraclude Clinical studies have explored entecavir for prophylaxis of HBV reactivation in patients undergoing rituximab-based chemotherapy, showing reduced incidence of hepatitis flares. Some transplant centers incorporate entecavir into combination regimens with hepatitis B immune globulin to prevent graft reinfection, although formal approval for this indication is pending. Investigational research is also evaluating entecavir in combination with immune-modulating agents for functional cure strategies, but these approaches remain experimental and should only be pursued within clinical trial settings. ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F); protect from excess heat and moisture. - Keep the container tightly closed and out of reach of children. - Do not use the medication after the expiration date printed on the package. - Dispose of unused tablets according to local hazardous waste guidelines or return them to a pharmacy for safe disposal. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Baraclude?** Yes, but keep the medication in its original labeled container, carry a copy of the prescribing information, and be aware of the importing regulations of your destination country. - **Should I take Baraclude with meals?** Entecavir can be taken with or without food; consistent timing each day helps maintain stable blood levels. - **Is it safe to consume alcohol while on Baraclude?** Moderate alcohol use may be tolerated, but excessive intake can worsen liver disease and diminish treatment benefit. Discuss your drinking habits with a healthcare professional. **Product Information** - **What does a Baraclude tablet look like?** The tablet is white, round, and film-coated, scored for easy splitting, although splitting is not recommended without professional advice. - **Are there any inactive ingredients I should be aware of?** Common excipients include lactose, magnesium stearate, and microcrystalline cellulose. Patients with severe lactose intolerance should consult a pharmacist. **Regulatory & Safety Nuances** - **Will Baraclude appear on a standard drug test?** Routine employment drug screens do not detect entecavir. It is not listed among substances screened for by most standard panels. - **Is Baraclude safe for older adults?** Elderly patients may have reduced renal function, necessitating dose adjustment and closer monitoring of kidney parameters. - **Can athletes use Baraclude without violating anti-doping rules?** Entecavir is not on the World Anti-Doping Agency (WADA) prohibited list; however, athletes should verify with their governing bodies before use. **Scientific & Clinical Curiosity** - **How does Baraclude compare to older HBV drugs like lamivudine?** Entecavir demonstrates higher potency and a markedly lower rate of resistance development compared with lamivudine, making it a preferred first-line option. - **When was Baraclude first approved?** Baraclude received its initial FDA approval in 2005 for the treatment of chronic hepatitis B in adults. ## Glossary **Nucleoside Analogue** : A synthetic compound that mimics natural nucleosides, interfering with viral DNA synthesis. **Viral Load** : The quantity of viral particles present in the blood, measured as copies per milliliter. **Bioequivalence** : The property whereby two drug products release the same amount of active ingredient into the bloodstream at the same rate and extent. **Renal Clearance** : The volume of plasma from which a drug is completely removed by the kidneys per unit time. ## Disclaimer The information presented about **Baraclude** is intended for general educational purposes and does not substitute professional medical advice. Treatment choices, including any off-label applications, should be made under the direct supervision of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health decisions. Our pharmacy service offers access to Baraclude for individuals who may encounter limited availability through conventional channels or who are seeking cost-effective alternatives. Always discuss initiation, modification, or discontinuation of any medication with your doctor.